GARDEN GROVE, Calif., Nov. 7, 2023 /PRNewswire/ — C3 International Inc., a pioneering pharmaceutical company, announces its response to the recent civil charges filed by the U.S. Securities and Exchange Commission (SEC) against the company, its groundbreaking product Idrasil and its…
News Ticker
- [ November 30, 2023 ] Validation Engineer – PSC Biotech – Aliso Viejo, CA Los Angeles Biotech Jobs
- [ November 30, 2023 ] Atara Biotherapeutics To Present Positive New Tab-cel® Clinical Data During Oral Session at ESMO Immuno-Oncology Annual Congress 2023 Los Angeles Biotech News
- [ November 29, 2023 ] Hoag’s Cardiothoracic Surgery Team Earns Highest Distinction in Three Surgical Areas Los Angeles Biotech News
- [ November 29, 2023 ] Dr. Lauren Papa Establishes Prestigious Scholarship for Aspiring Healthcare Professionals in Los Angeles, CA Los Angeles Biotech News
- [ November 29, 2023 ] Dr. Jessica Clague DeHart of Claremont Graduate University and LYTE Foundation to receive data and findings of the important Health of Women (HOW) Study® and the Metastatic Breast Cancer Collateral Damage (MBCCD) Project Los Angeles Biotech News
Copyright © 2023 Biotech Networks, LLC
